Premium
Symptomatic and syndromal anxiety and depression
Author(s) -
Ninan Philip T.,
Berger Joseph
Publication year - 2001
Publication title -
depression and anxiety
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.634
H-Index - 129
eISSN - 1520-6394
pISSN - 1091-4269
DOI - 10.1002/da.1049
Subject(s) - anxiety , antidepressant , comorbidity , depression (economics) , psychology , psychiatry , tricyclic antidepressant , clinical psychology , cognition , medicine , economics , macroeconomics
The diagnosis of anxiety disorders and major depression can be reliably made based on signs and symptoms. However there are significant limitations to the current system of classification including overlapping criteria, high comorbidity, and the issue of subthreshold syndromes. The literature on treatment response documents that selective serotonin reuptake inhibitors are effective in the treatment of the various anxiety disorders, including when comorbid major depression is present. The literature also suggests that tricyclic antidepressant medications have superior benefits over selective serotonin reuptake inhibitors in major depression. Examination of the functional anatomy of the fear and reward systems may shed light on the underlying processes in the anxiety and depressive disorders. Such an approach points out the importance of addressing avoidance behaviors, which may be more responsive to cognitive behavioral treatments than pharmacological agents. Depression and Anxiety 14:79–85, 2001. © 2001 Wiley‐Liss, Inc.